Cytoreductive Surgery (CRS) is a surgical procedure used to remove cancer cells from the body. It is typically used in combination with other treatments such as chemotherapy and radiation therapy. The goal of CRS is to reduce the number of cancer cells in the body and thereby improve the chances of survival. CRS involves removing the tumor, along with the surrounding tumor tissue and lymph nodes. This is done by making an incision in the skin and cutting away the cancerous tissue. In some cases, the entire organ may need to be removed. This is known as an organ resection. CRS may be used to treat cancer in many different organs, such as the ovaries, lungs, liver, pancreas, and colon. It is most often used for ovarian cancer, but may be used for other types of cancer as well. CRS is a complex procedure and is often used in combination with other treatments. The procedure can be lengthy and the recovery time can be long. The risks associated with CRS include infection, bleeding, and damage to surrounding organs.
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin Khameh, Baylor College of Medicine, United States
Title : Prevalence and determinants of health facility-based deliveries among women in urban slum settings: Evidence from Lubaga division, Kampala
Josephine Nakakawa, Nsambya Hospital, Kampala, Uganda
Title : Changing trends in women’s healthcare: From adolescence to menopause and gynaecologic cancer care
Gangadhararao Koneru, nrias, India
Title : Changing trends in women’s healthcare: From adolescence to menopause and gynaecologic cancer care
Gangadhararao Koneru, nrias, India
Title : Endometrial functions in recurrent pregnancy loss
Nicoletta Di Simone, Humanitas University Milan, Italy
Title : Peritoneum an organ and its role in reproductive regeneration
Pravin Mhatre, G S Medical College KEM, India